Literature DB >> 28617450

A human intestinal M-cell-like model for investigating particle, antigen and microorganism translocation.

Ana Beloqui1, David J Brayden2, Per Artursson3,4, Véronique Préat1, Anne des Rieux1,5.   

Abstract

The specialized microfold cells (M cells) in the follicle-associated epithelium (FAE) of intestinal Peyer's patches serve as antigen-sampling cells of the intestinal innate immune system. Unlike 'classical' enterocytes, they are able to translocate diverse particulates without digesting them. They act as pathways for microorganism invasion and mediate food tolerance by transcellular transport of intestinal microbiota and antigens. Their ability to transcytose intact particles can be used to develop oral drug delivery and oral immunization strategies. This protocol describes a reproducible and versatile human M-cell-like in vitro model. This model can be exploited to evaluate M-cell transport of microparticles and nanoparticles for protein, drug or vaccine delivery and to study bacterial adherence and translocation across M cells. The inverted in vitro M-cell model consists of three main steps. First, Caco-2 cells are seeded at the apical side of the inserts. Second, the inserts are inverted and B lymphocytes are seeded at the basolateral side of the inserts. Third, the conversion to M cells is assessed. Although various M-cell culture systems exist, this model provides several advantages over the rest: (i) it is based on coculture with well-established differentiated human cell lines; (ii) it is reproducible under the conditions described herein; (iii) it can be easily mastered; and (iv) it does not require the isolation of primary cells or the use of animals. The protocol requires skills in cell culture and microscopy analysis. The model is obtained after 3 weeks, and transport experiments across the differentiated model can be carried out over periods of up to 10 h.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28617450     DOI: 10.1038/nprot.2017.041

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  39 in total

1.  Cell culture modeling of specialized tissue: identification of genes expressed specifically by follicle-associated epithelium of Peyer's patch by expression profiling of Caco-2/Raji co-cultures.

Authors:  David Lo; Wendy Tynan; Janet Dickerson; Melinda Scharf; Judith Cooper; Daragh Byrne; David Brayden; Lisa Higgins; Claire Evans; Daniel J O'Mahony
Journal:  Int Immunol       Date:  2004-01       Impact factor: 4.823

2.  Expression of specific markers and particle transport in a new human intestinal M-cell model.

Authors:  E Gullberg; M Leonard; J Karlsson; A M Hopkins; D Brayden; A W Baird; P Artursson
Journal:  Biochem Biophys Res Commun       Date:  2000-12-29       Impact factor: 3.575

Review 3.  Keynote review: intestinal Peyer's patch M cells and oral vaccine targeting.

Authors:  David J Brayden; Mark A Jepson; Alan W Baird
Journal:  Drug Discov Today       Date:  2005-09-01       Impact factor: 7.851

4.  Transport of nanoparticles across an in vitro model of the human intestinal follicle associated epithelium.

Authors:  Anne des Rieux; Eva G E Ragnarsson; Elisabet Gullberg; Véronique Préat; Yves-Jacques Schneider; Per Artursson
Journal:  Eur J Pharm Sci       Date:  2005 Jul-Aug       Impact factor: 4.384

5.  Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles.

Authors:  Tommy Cedervall; Iseult Lynch; Stina Lindman; Tord Berggård; Eva Thulin; Hanna Nilsson; Kenneth A Dawson; Sara Linse
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-31       Impact factor: 11.205

6.  Helodermin-loaded nanoparticles: characterization and transport across an in vitro model of the follicle-associated epithelium.

Authors:  Anne des Rieux; Virginie Fievez; Maryam Momtaz; Christophe Detrembleur; Maria Alonso-Sande; Jan Van Gelder; Annick Cauvin; Yves-Jacques Schneider; Véronique Préat
Journal:  J Control Release       Date:  2006-12-29       Impact factor: 9.776

7.  Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers.

Authors:  Ina Hubatsch; Eva G E Ragnarsson; Per Artursson
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

8.  Development of an advanced intestinal in vitro triple culture permeability model to study transport of nanoparticles.

Authors:  Christa Schimpel; Birgit Teubl; Markus Absenger; Claudia Meindl; Eleonore Fröhlich; Gerd Leitinger; Andreas Zimmer; Eva Roblegg
Journal:  Mol Pharm       Date:  2014-02-06       Impact factor: 4.939

9.  Drug delivery to inflamed colon by nanoparticles: comparison of different strategies.

Authors:  Régis Coco; Laurence Plapied; Vincent Pourcelle; Christine Jérôme; David J Brayden; Yves-Jacques Schneider; Véronique Préat
Journal:  Int J Pharm       Date:  2012-07-20       Impact factor: 5.875

10.  Transcytosis of murine-adapted bovine spongiform encephalopathy agents in an in vitro bovine M cell model.

Authors:  Kohtaro Miyazawa; Takashi Kanaya; Ikuro Takakura; Sachi Tanaka; Tetsuya Hondo; Hitoshi Watanabe; Michael T Rose; Haruki Kitazawa; Takahiro Yamaguchi; Shigeru Katamine; Noriyuki Nishida; Hisashi Aso
Journal:  J Virol       Date:  2010-09-22       Impact factor: 5.103

View more
  10 in total

1.  Induced Differentiation of M Cell-like Cells in Human Stem Cell-derived Ileal Enteroid Monolayers.

Authors:  Alyssa C Fasciano; Sarah E Blutt; Mary K Estes; Joan Mecsas
Journal:  J Vis Exp       Date:  2019-07-26       Impact factor: 1.355

Review 2.  Identifying human and murine M cells in vitro.

Authors:  Ana Klisuric; Benjamin Thierry; Ludivine Delon; Clive A Prestidge; Rachel J Gibson
Journal:  Exp Biol Med (Maywood)       Date:  2019-03-24

3.  Investigation of Twenty Metal, Metal Oxide, and Metal Sulfide Nanoparticles' Impact on Differentiated Caco-2 Monolayer Integrity.

Authors:  Ninell P Mortensen; Maria Moreno Caffaro; Purvi R Patel; Md Jamal Uddin; Shyam Aravamudhan; Susan J Sumner; Timothy R Fennell
Journal:  NanoImpact       Date:  2020-02-13

4.  Chips-on-a-plate device for monitoring cellular migration in a microchannel-based intestinal follicle-associated epithelium model.

Authors:  Young Lee; Soo Jee Kim; Je-Kyun Park
Journal:  Biomicrofluidics       Date:  2019-12-24       Impact factor: 2.800

5.  New In Vitro Coculture Model for Evaluating Intestinal Absorption of Different Lipid Nanocapsules.

Authors:  Norraseth Kaeokhamloed; Emillie Roger; Jérôme Béjaud; Nolwenn Lautram; Florence Manero; Rodolphe Perrot; Chadi Abbara; Marie Briet; Samuel Legeay
Journal:  Pharmaceutics       Date:  2021-04-21       Impact factor: 6.321

6.  Mucosal immunity-mediated modulation of the gut microbiome by oral delivery of probiotics into Peyer's patches.

Authors:  Sisi Lin; Subhajit Mukherjee; Juanjuan Li; Weiliang Hou; Chao Pan; Jinyao Liu
Journal:  Sci Adv       Date:  2021-05-12       Impact factor: 14.136

7.  Biomimetic thiamine- and niacin-decorated liposomes for enhanced oral delivery of insulin.

Authors:  Haisheng He; Yi Lu; Jianping Qi; Weili Zhao; Xiaochun Dong; Wei Wu
Journal:  Acta Pharm Sin B       Date:  2017-12-23       Impact factor: 11.413

8.  Development of an M cell targeted nanocomposite system for effective oral protein delivery: preparation, in vitro and in vivo characterization.

Authors:  Jae Geun Song; Sang Hoon Lee; Hyo-Kyung Han
Journal:  J Nanobiotechnology       Date:  2021-01-09       Impact factor: 10.435

Review 9.  Oral delivery of protein and peptide drugs: from non-specific formulation approaches to intestinal cell targeting strategies.

Authors:  Guanyu Chen; Weirong Kang; Wanqiong Li; Shaomeng Chen; Yanfeng Gao
Journal:  Theranostics       Date:  2022-01-01       Impact factor: 11.556

10.  Transcytosis subversion by M cell-to-enterocyte spread promotes Shigella flexneri and Listeria monocytogenes  intracellular bacterial dissemination.

Authors:  Camille Rey; Yuen-Yan Chang; Patricia Latour-Lambert; Hugo Varet; Caroline Proux; Rachel Legendre; Jean-Yves Coppée; Jost Enninga
Journal:  PLoS Pathog       Date:  2020-04-13       Impact factor: 6.823

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.